As of November 6, 2026, 4 holders' latest Schedule 13D or 13G filings report owning 5% or more of Teladoc Health Inc. The largest reported stake is Vanguard Portfolio Management's, at 6.97%. 7 filings are on record since July 29, 2025 (Schedule 13G, April 29, 2026).
Sell to companies like Teladoc Health Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Dimensional Fund Advisors LP · Sole voting: 8,935,731 · Shared voting: 0 · Sole dispositive: 9,100,047 · Shared dispositive: 0 · SCHEDULE 13G, 2026-10-08
- · Reporting person: Voss Value Master Fund, LP · Sole voting: 1,803,606 · Shared voting: 0 · Sole dispositive: 1,803,606 · Shared dispositive: 0 · SCHEDULE 13G, 2026-06-22
- · Reporting person: Vanguard Capital Management · Sole voting: 1,348,137 · Shared voting: 0 · Sole dispositive: 9,205,306 · Shared dispositive: 0 · SCHEDULE 13G, 2026-04-30
- · Reporting person: Vanguard Portfolio Management · Sole voting: 156,172 · Shared voting: 0 · Sole dispositive: 12,451,266 · Shared dispositive: 0 · SCHEDULE 13G, 2026-04-29
- · Holder: The Vanguard Group · Percent: 0% · SCHEDULE 13G/A
Teladoc Health Inc has 7 Schedule 13D or 13G filings on record since 2025-07-29. 4 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Vanguard Portfolio Management | 6.97% | 12,451,266 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| Vanguard Capital Management | 5.16% | 9,205,306 | SCHEDULE 13G, 2026-04-30 | 2026-03-31 |
| Voss Capital, LP | 5% | 9,025,722 | SCHEDULE 13G, 2026-06-22 | 2026-06-17 |
| Dimensional Fund Advisors LP | 5% | 9,100,047 | SCHEDULE 13G, 2026-10-08 | 2026-09-30 |
| Point72 Asset Management, L.P. | 3.3% | 5,795,178 | SCHEDULE 13G/A, 2025-11-14 | 2025-09-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
Holding shares or following this stake? See who's behind Teladoc Health Inc and the warning signs.
Free to see. No signup.
Keep reading
More on Teladoc Health Inc and the records around it.
Teladoc Health Inc elsewhere on the record
- Leadership changes Sep 2026
- Who owns it
Companies that share a holder
- Voss Value Master Fund, LP also filed stake reports on 13 other companies: Five9, Inc. (Oct 2026), Cellebrite DI Ltd. (Aug 2026), ALTA EQUIPMENT GROUP INC. (Jul 2026)
- Point72 Asset Management, L.P. also filed stake reports on 90 other companies: Immunocore Holdings plc (Nov 2026), Target Hospitality Corp. (Nov 2026), E.W. SCRIPPS Co (Oct 2026)
- Dimensional Fund Advisors LP also filed stake reports on 366 other companies: Acadia Healthcare Co Inc (Oct 2026), ADT Inc (Oct 2026), AGCO Corp (Oct 2026)
Watch Teladoc Health Inc
Get an email when Teladoc Health Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Teladoc Health Inc?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Teladoc Health Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Teladoc Health Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Vanguard Portfolio Management | 156,172 | 0 | 12,451,266 | 0 | SCHEDULE 13G, 2026-04-29 |
| Vanguard Capital Management | 1,348,137 | 0 | 9,205,306 | 0 | SCHEDULE 13G, 2026-04-30 |
| Voss Value Master Fund, LP | 1,803,606 | 0 | 1,803,606 | 0 | SCHEDULE 13G, 2026-06-22 |
| Voss Value-Oriented Special Situations Fund, LP | 200,000 | 0 | 200,000 | 0 | SCHEDULE 13G, 2026-06-22 |
| Voss Advisors GP, LLC | 2,003,606 | 0 | 2,003,606 | 0 | SCHEDULE 13G, 2026-06-22 |
| Voss Capital, LP | 7,690,451 | 1,335,271 | 7,690,451 | 1,335,271 | SCHEDULE 13G, 2026-06-22 |
| Cocke Travis W. | 7,690,451 | 1,335,271 | 7,690,451 | 1,335,271 | SCHEDULE 13G, 2026-06-22 |
| Dimensional Fund Advisors LP | 8,935,731 | 0 | 9,100,047 | 0 | SCHEDULE 13G, 2026-10-08 |
The latest filing identifies Teladoc Health Inc by CUSIP 87918A105 and gives its principal executive office as 2 Manhattanville Road, Suite 203, Purchase (SCHEDULE 13G, 2026-10-08).
What the percentages are based on
The aggregate percentage of the Shares reported owned by each person named herein is based upon 180,513,087 Shares outstanding as of April 23, 2026, which is the total number of Shares outstanding as disclosed in the Issuer's Form 10Q filed with the Securities and Exchange Commission on April 30, 2026.Voss Capital, LP, SCHEDULE 13G, 2026-06-22
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-29 | The Vanguard Group | 11.98% | SCHEDULE 13G/A |
| 2025-11-14 | Point72 Asset Management, L.P. | 3.3% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-29 | Vanguard Portfolio Management | 6.97% | SCHEDULE 13G |
| 2026-04-30 | Vanguard Capital Management | 5.16% | SCHEDULE 13G |
| 2026-06-22 | Voss Capital, LP | 5% | SCHEDULE 13G |
| 2026-10-08 | Dimensional Fund Advisors LP | 5% | SCHEDULE 13G |
Questions about who owns Teladoc Health Inc
Who owns Teladoc Health Inc?
On this page, 4 holders' latest ownership filings report 5% or more of Teladoc Health Inc: Vanguard Portfolio Management (6.97%, Schedule 13G, filed 2026-04-29), Vanguard Capital Management (5.16%, Schedule 13G, filed 2026-04-30), Voss Capital, LP (5%, Schedule 13G, filed 2026-06-22) and Dimensional Fund Advisors LP (5%, Schedule 13G, filed 2026-10-08).
Who are the largest shareholders of Teladoc Health Inc?
By the share each holder's latest filing reports, the largest holders of Teladoc Health Inc on this page are Vanguard Portfolio Management (6.97%), Vanguard Capital Management (5.16%) and Voss Capital, LP (5%).
When did Vanguard Portfolio Management buy into Teladoc Health Inc?
The filings give report dates, not purchase dates. The earliest filing from Vanguard Portfolio Management on this page is the Schedule 13G, filed 2026-04-29, reporting 6.97%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 7 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Teladoc Health Inc
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 25, 2026 | Leadership change: Adam C. Vandervoort departs, Chief Legal Officer | — | Leadership changes | Source |
| August 31, 2026 | Leadership change: Michael Grasher appointed, Chief Financial Officer | — | Leadership changes | Source |
| August 13, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| August 3, 2026 | Leadership change: Mark V. Anquillare appointed, Director | — | Leadership changes | Source |
| March 30, 2026 | Leadership change: Susan R. Salka appointed, Director | — | Leadership changes | Source |
Tools for this story
Each opens in a new tab, filled in for Teladoc Health Inc. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.